NCT05486234

Brief Summary

The study will test a computerized treatment with subjects ages 13-17 years who are seeking treatment for alcohol and/or cannabis use. Follow-up assessments will be conducted at one- and three-months following treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jan 2023Aug 2026

First Submitted

Initial submission to the registry

August 1, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 25, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

3.5 years

First QC Date

August 1, 2022

Last Update Submit

March 5, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in cannabis use as assessed by Timeline Followback

    The TLFB is a calendar-assisted semi-structured interview that will be used to assess cannabis and alcohol use since the last assessment. The TLFB will assess the number of days a person used cannabis over the past 90 days compared to the 90 days prior to enrolling in this study.

    Baseline and Three-Month Follow-up

  • Change in alcohol use as assessed by Timeline Followback

    The TLFB is a calendar-assisted semi-structured interview that will be used to assess cannabis and alcohol use since the last assessment. The TLFB will assess the number of days a person consumed alcohol over the past 90 days compared to the 90 days prior to enrolling in this study.

    Baseline and Three-Month Follow-up

  • Change in Cannabis Approach Bias (D-Score)

    D scores will be calculated for each participant at baseline, posttest, and three-month follow-up. Participants' mean reaction times (RTs) during the approach cannabis trials will be subtracted from the mean avoid cannabis trial RTs. These scores are then divided by the SD across all cannabis trials. Positive scores indicate an approach bias for cannabis stimuli.

    Baseline, One-Week Follow-up, and Three-Month Follow-up

  • Change Cannabis Approach Bias (D-Score)

    D scores will be calculated for each participant at baseline, posttest, and three-month follow-up. Participants' mean reaction times (RTs) during the approach alcohol trials will be subtracted from the mean avoid alcohol trial RTs. These scores are then divided by the SD across all alcohol trials. Positive scores indicate an approach bias for alcohol stimuli.

    Baseline, One-Week Follow-up, and Three-Month Follow-up

Study Arms (2)

Group A: Treatment Group

EXPERIMENTAL
Behavioral: modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias

Group B: Control Group

SHAM COMPARATOR
Behavioral: modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.

Interventions

Participants will undergo a baseline assessment before completing computerized tasks. During the baseline assessment, participants will be asked questions about alcohol and cannabis use. We will also ask questions about the way participants think about things, past life experiences related to substance use, and questions about how participants feel about reducing their substance use. Then, participants will complete a series computerized tasks where they will push and pull a joystick in response to images that are presented on a screen or where they will try to get a high score. During the computerized tasks, we will also be measuring brain activity using EEG. During the study, participants will also be asked to respond to questions about their health and behavior using an app on a smartphone or tablet using a secure program. Participants in the Treatment Group will then complete four sessions of the modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias.

Group A: Treatment Group

Participants will undergo a baseline assessment before completing computerized tasks. During the baseline assessment, participants will be asked questions about alcohol and cannabis use. We will also ask questions about the way participants think about things, past life experiences related to substance use, and questions about how participants feel about reducing their substance use. Then, participants will complete a series computerized tasks where they will push and pull a joystick in response to images that are presented on a screen or where they will try to get a high score. During the computerized tasks, we will also be measuring brain activity using EEG. During the study, participants will also be asked to respond to questions about their health and behavior using an app on a smartphone or tablet using a secure program. Participants in the Control Group will then complete four sessions of an Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.

Group B: Control Group

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • between the ages of 13 and 17
  • be seeking treatment for either cannabis or alcohol use;
  • report co-occurring alcohol and cannabis use during the past three months (i.e., participants who report using both alcohol and cannabis during the three months prior to participation in the study, regardless of if the use was simultaneous)
  • have a caregiver willing to participate and provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

RECRUITING

MeSH Terms

Conditions

Alcohol DrinkingSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorChemically-Induced DisordersMental Disorders

Central Study Contacts

Austin M Hahn, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2022

First Posted

August 3, 2022

Study Start

January 25, 2023

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations